Citadel Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.8M Buy
94,200
+4,600
+5% +$1.16M ﹤0.01% 2358
2025
Q4
$25.5M Buy
89,600
+41,800
+87% +$13.1M ﹤0.01% 2088
2025
Q3
$14.8M Sell
47,800
-7,500
-14% -$2.35M ﹤0.01% 2716
2025
Q2
$17.4M Sell
55,300
-18,500
-25% -$5.34M ﹤0.01% 2311
2025
Q1
$19.4M Buy
73,800
+2,300
+3% +$622K ﹤0.01% 2075
2024
Q4
$18.7M Sell
71,500
-24,800
-26% -$6.25M ﹤0.01% 2231
2024
Q3
$22.4M Sell
96,300
-18,800
-16% -$3.86M ﹤0.01% 1928
2024
Q2
$23.2M Buy
115,100
+15,000
+15% +$2.7M ﹤0.01% 1849
2024
Q1
$17.2M Sell
100,100
-49,600
-33% -$9.25M ﹤0.01% 2244
2023
Q4
$32.5M Sell
149,700
-1,000
-0.7% -$172K 0.01% 1545
2023
Q3
$24M Buy
150,700
+105,600
+234% +$23.6M 0.01% 1671
2023
Q2
$13M Sell
45,100
-106,900
-70% -$32.5M ﹤0.01% 2348
2023
Q1
$48.5M Buy
152,000
+106,600
+235% +$31.6M 0.01% 1099
2022
Q4
$13.4M Buy
45,400
+15,500
+52% +$4.27M ﹤0.01% 2436
2022
Q3
$6.86M Sell
29,900
-32,900
-52% -$8.24M ﹤0.01% 3353
2022
Q2
$13.7M Buy
62,800
+24,700
+65% +$5.61M ﹤0.01% 2282
2022
Q1
$10.1M Sell
38,100
-13,600
-26% -$3.34M ﹤0.01% 2935
2021
Q4
$13.8M Buy
51,700
+18,600
+56% +$5.4M ﹤0.01% 2546
2021
Q3
$9.41M Buy
33,100
+21,400
+183% +$6.1M ﹤0.01% 3189
2021
Q2
$3.21M Buy
11,700
+3,000
+34% +$815K ﹤0.01% 5433
2021
Q1
$2.27M Sell
8,700
-5,500
-39% -$1.47M ﹤0.01% 6092
2020
Q4
$3.63M Sell
14,200
-7,200
-34% -$1.79M ﹤0.01% 4251
2020
Q3
$5.06M Buy
21,400
+4,400
+26% +$927K ﹤0.01% 3143
2020
Q2
$3.3M Sell
17,000
-13,200
-44% -$2.52M ﹤0.01% 3695
2020
Q1
$5M Buy
30,200
+13,200
+78% +$2.41M ﹤0.01% 2701
2019
Q4
$2.91M Sell
17,000
-11,100
-40% -$1.85M ﹤0.01% 3824
2019
Q3
$4.63M Buy
28,100
+8,600
+44% +$1.21M ﹤0.01% 3220
2019
Q2
$2.33M Buy
19,500
+1,800
+10% +$185K ﹤0.01% 4263
2019
Q1
$1.68M Buy
17,700
+5,000
+39% +$429K ﹤0.01% 4749
2018
Q4
$1.01M Sell
12,700
-8,700
-41% -$736K ﹤0.01% 5297
2018
Q3
$2.27M Buy
21,400
+1,100
+5% +$103K ﹤0.01% 4202
2018
Q2
$1.74M Buy
20,300
+10,600
+109% +$951K ﹤0.01% 4317
2018
Q1
$841K Buy
9,700
+500
+5% +$38.8K ﹤0.01% 5064
2017
Q4
$635K Buy
+9,200
New +$604K ﹤0.01% 5320
2017
Q3
Sell
-6,700
Closed -$344K 7913
2017
Q2
$344K Buy
+6,700
New +$291K ﹤0.01% 5692
2016
Q1
Sell
-4,800
Closed -$181K 7698
2015
Q4
$181K Sell
4,800
-3,200
-40% -$108K ﹤0.01% 5932
2015
Q3
$207K Sell
8,000
-600
-7% -$18.2K ﹤0.01% 6099
2015
Q2
$266K Buy
8,600
+6,300
+274% +$186K ﹤0.01% 5923
2015
Q1
$77K Sell
2,300
-4,800
-68% -$162K ﹤0.01% 7068
2014
Q4
$327K Buy
7,100
+3,100
+78% +$133K ﹤0.01% 5309
2014
Q3
$147K Buy
4,000
+1,200
+43% +$43.8K ﹤0.01% 6042
2014
Q2
$111K Sell
2,800
-200
-7% -$7.69K ﹤0.01% 6152
2014
Q1
$142K Sell
3,000
-1,800
-38% -$79.6K ﹤0.01% 5857
2013
Q4
$178K Sell
4,800
-2,600
-35% -$96K ﹤0.01% 5141
2013
Q3
$268K Sell
7,400
-1,400
-16% -$47K ﹤0.01% 4484
2013
Q2
$276K Buy
+8,800
New +$249K ﹤0.01% 4373

Other funds holding PODD

Citadel Advisors's PODD Position: Q1 2026 in Review

Citadel Advisors increased its Insulet (PODD) stake by 58% in Q1 2026, buying an estimated $14.1M and bringing the position to 153,439 shares worth $32.2M. The position accounts for 0.01% of the portfolio, ranked #1785.

Citadel Advisors first reported a position in PODD in Q2 2013 and has held it in 50 quarters since. The position peaked at $304M in Q2 2024. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Citadel Advisors held 153,439 shares of Insulet worth $32.2M as of Q1 2026.
  • Citadel Advisors bought 56,076 Insulet shares in Q1 2026, an estimated $14.1M.
  • Insulet made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1785 holding.
  • Citadel Advisors first reported a position in Insulet in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Insulet position peaked at $304M in Q2 2024.
  • 785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.